Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.82 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.68 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.68 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.68 |
| ▸ | NT5E | P21589 | 2/20 | 0.60 |
| ▸ | TGM2 | P21980 | 1/20 | 0.56 |
| ▸ | IMPDH2 | P12268 | 5/20 | 0.54 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.54 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.54 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.54 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.54 |
| ▸ | TYMS | P04818 | 1/20 | 0.54 |
| ▸ | KRAS | P01116 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25171429 | 1.00 | POLB (0.82) | POLBP2RY2P2RY4P2RY6NT5E | |
| SCHEMBL17117812 | 1.00 | POLB (0.82) | POLBP2RY2P2RY4P2RY6NT5E | |
| SCHEMBL18785118 | 1.00 | POLB (0.82) | POLBP2RY2P2RY4P2RY6NT5E | |
| SCHEMBL16678590 | 1.00 | POLB (0.82) | POLBP2RY2P2RY4P2RY6NT5E | |
| SCHEMBL1971161 | 1.00 | POLB (0.82) | POLBP2RY2P2RY4P2RY6NT5E | |
| Water SCHEMBL7247857 | 0.99 | POLB (0.81) | POLBP2RY2P2RY4P2RY6NT5E | |
| SCHEMBL2231785 | 0.99 | POLB (0.81) | POLBP2RY2P2RY4P2RY6NT5E | |
| SCHEMBL29258727 | 0.96 | POLB (0.77) | POLBP2RY2P2RY4P2RY6NT5E | |
| SCHEMBL30927571 | 0.96 | POLB (0.77) | POLBP2RY2P2RY4P2RY6NT5E | |
| Triphosphate SCHEMBL27909453 | 0.96 | POLB (0.82) | POLBP2RY2P2RY4P2RY6NT5E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6827 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260146277-A1 | APPLICATION FOR PEPTIDE NUCLEIC ACID (PNA) BLOCKER | BECTON, DICKINSON AND COMPANY (US) | 2026-05-28 | — | — | US | claimed |
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260132399-A1 | BEAD-BASED SINGLE CELL SECRETOME ANALYSIS | BECTON DICKINSON AND CO (US) | 2026-05-14 | — | — | US | claimed |
| US-12584168-B2 | Sample preparation method | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2026-03-24 | — | — | US | claimed |
| US-20260071254-A1 | POLYMERASE MEDIATED END MODIFICATION OF ABSEQ | BECTON DICKINSON CO (US) | 2026-03-12 | — | — | US | claimed |
| EP-4006168-B1 | METHOD OF CHARACTERIZING A TARGET RIBONUCLEIC ACID (RNA) COMPRISING FORMING A COMPLEMENTARY POLYNUCLEOTIDE WHICH MOVES THROUGH A TRANSMEMBRANE PORE | OXFORD NANOPORE TECH PLC (GB) | 2025-12-17 | — | — | EP | claimed |
| US-12473593-B2 | Method of characterizing a target ribonucleic acid (RNA) comprising forming a complementary polynucleotide which moves through a transmembrane pore | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2025-11-18 | — | — | US | claimed |
| EP-4644565-A1 | SEQUENCING METHOD | BGI Shenzhen (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4399327-B1 | NON-SEQUENCING PCR-BASED METHOD FOR DETECTION OF ANTIBODY-CONJUGATED OLIGONUCLEOTIDES | BECTON DICKINSON CO (US) | 2025-10-29 | — | — | EP | claimed |
| EP-4634200-A1 | ENZYMATIC SYNTHESIS OF NTP AND NQP | Codexis, Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| US-5009994-A | Uniform distribution | EM DIAGNOSTIC SYSTEMS, INC. (US) | 1991-04-23 | — | — | US | claimed |
| WO-1990015814-A1 | NUCLEASE RESISTANT, SINGLE-STRANDED, NON-NATURALLY OCCURRING NUCLEIC ACID MOLECULES | MEIOGENICS, INC. (US) | 1990-12-27 | — | — | WO | claimed |
| EP-0183964-B1 | DNA SEQUENCE | TEIJIN LIMITED (JP) | 1990-03-14 | — | — | EP | claimed |
| EP-0090417-B1 | PROCESS FOR PRODUCING 3'-DEOXYGUANOSINE | Yamasa Shoyu Kabushiki Kaisha (JP) | 1989-03-01 | — | — | EP | claimed |
| US-4786719-A | DNA sequence | TEIJIN, LIMITED (JP) | 1988-11-22 | — | — | US | claimed |
| EP-0183964-A1 | DNA sequence | TEIJIN LIMITED (JP) | 1986-06-11 | — | — | EP | claimed |
| US-4594321-A | Reacting guanine derivative with phosphate | YAMASA SHOYU KABUSHIKI KAISHA (JP) | 1986-06-10 | — | — | US | claimed |
| US-4594320-A | Reacting guanine derivative with phosphate compound | YAMASA SHOYU KABUSHIKI KAISHA (JP) | 1986-06-10 | — | — | US | claimed |
| EP-0146743-A2 | Gene fragments derived from human immunoglobulin gene | TEIJIN LIMITED (JP) | 1985-07-03 | — | — | EP | claimed |
| EP-0090417-A2 | Process for producing 3'-deoxyguanosine | Yamasa Shoyu Kabushiki Kaisha (JP) | 1983-10-05 | — | — | EP | claimed |